Researchers sought to find whether there was a relationship between patient-reported outcomes and overall survival after hematopoietic stem cell transplantation.
Researchers sought to determine whether post-transplant carfilzomib, lenalidomide, and dexamethasone would have superior PFS in patients with multiple myeloma.
Researchers sought to determine whether varicella-zoster virus vaccination with a recombinant vaccine would show results in patients who underwent HSCT.
Researchers sought to determine whether leukocyte A&R would be linked with cancer relapse and survival after hematopoietic cell transplant.
There was no significant difference in transplant-related mortality or overall survival.
A project to reverse an increase in CLABSIs on an HSCT inpatient unit and its ongoing impact were described at the Annual ONS Congress.
Researchers sought to determine the effect of transplant-related complications and socioeconomic factors on revaccination schedule adherence among pediatric patients following allo-HSCT.
Researchers sought to determine whether adding MSC to basiliximab and a calcineurin inhibitor would improve outcomes in patients with aGVHD after HSCT.
Researchers sought to determine whether there were long-term benefits for patients with hematologic malignancies treated with allo-HSCT and omidubicel.
Researchers sought to determine whether there is a link between outcomes of hematopoietic transplantation and treosulfan exposure in high-risk thalassemia major.
